The Australasian Melanoma Conference will bring together key stakeholders to discuss exciting advances in this disease from ground-breaking discoveries to practical clinical management.
Over the last two decades, the pace of discovery in melanoma research has been breathtaking, with consequential and profound advances in treatment. These developments are already significantly impacting on outcomes with a proportion of patients with widespread metastatic disease now surviving long term. In turn, these advances have revealed the next order of priorities: disease prevention and early detection, gaps in the therapy landscape and survivorship issues.
Central to addressing these will be a focus on integrating research and clinical care. This will speed the path to further improvements in patient outcomes and also illuminate the critical research questions that will be foci of future investment and effort. Via scientific and educational fora, the 2018 Australasian Melanoma Conference in Melbourne will provide cutting-edge insights into understanding of disease biology and the modern management of melanoma patients.
The meeting will feature keynote addresses from national and international experts outlining the current research and clinical landscape of melanoma. Participants will have the opportunity to focus on specific areas of interest including diagnosis, survivorship, and the treatment of early stage and advanced disease, with particular attention to new targeted and immune therapies. The conference will be of value to all who care for patients with melanoma, including primary care practitioners.
For more information and to register: http://www.australasianmelanoma.org/